abstract: provided herein are tri-salt compounds comprising a compound having two acidic functional groups and one basic functional groups (e.g., aspartate or glutamate), metformin, and polyunsaturated fatty acids, such as eicosapentaenoate or docosahexaenoate. the salts may be used in the treatment of diabetes, diabetes with concomitant dyslipidemia (e.g., high triglycerides) and diabetes exacerbated cardiovascular complications, such as cardiac arrhythmia, cardiac ischemia, myocardial infarction, cardiomyopathy, and stroke. The compounds of this invention are also useful in treating obesity. Patent Summary: "Metformin tri-salt form" The present invention relates to the provision of tri-salt compounds comprising a compound having two acidic functional groups and a basic functional group (e.g., aspartate and glutamate), metformin, and polyunsaturated fatty acids, such as eicosapentanoate or decosaexanoate. The salts may be used in the treatment of diabetes, diabetes such as concomitant dyslipidemia (eg, high triglycerides) and diabetes with exacerbated cardiovascular complications such as cardiac arrhythmia, cardiac ischemia, myocardial infarction, cardiomyopathy and stroke. The compounds of this invention are also useful in treating obesity.abstract: provided herein are tri-salt compounds comprising a compound having two acidic functional groups and one basic functional groups (e.g., aspartate or glutamate), metformin, and polyunsaturated fatty acids, such as eicosapentaenoate or docosahexaenoate. the salts can be used in the treatment of diabetes, diabetes with concomitant dyslipidemia (e.g. , high triglycerides) and diabetes exacerbated cardiovascular complications, such as cardiac arrhythmia, cardiac ischemia, myocardial infarction, cardiomyopathy, and stroke. the compounds of this invention are also useful in treating obesity. tradução do resumo resumo patente de invenção: "forma de tri-sais de metformina" a presente invenção refere-se à provisão de compostos d
